TXL enhances cardiac microvascular perfusion and mitigates myocardial ischemia/reperfusion damage by safeguarding endothelial cells and cardiomyocytes against ischemia/reperfusion-induced apoptosis. This evidence concerns the gene TXNL1 and ischemia.